N1b期甲状腺乳头状癌治疗后复发危险因素
该研究纳入437例接受全甲状腺切除、中央区及侧颈区治疗性颈清扫和术后放射性碘消融的N1b期甲状腺乳头状癌患者,中位随访83个月,复发81例(18.1%)。多因素分析显示侧颈区淋巴结比率>0.25及术后刺激/非刺激甲状腺球蛋白升高是任何部位无复发生存的独立预测因素。
要点
- 侧颈区淋巴结比率>0.25与复发风险独立相关(调整HR=2.099)。
- 术后刺激甲状腺球蛋白>5.0 ng/mL为独立预测因素(HR=3.172)。
- 术后非刺激甲状腺球蛋白>0.1 ng/mL为独立预测因素(HR=3.200)。
核心结论
- N1b期甲状腺乳头状癌治疗后复发可由侧颈区淋巴结比率和术后血清甲状腺球蛋白水平预测。
研究设计与样本
- 回顾性队列研究,纳入437例连续接受全甲状腺切除、中央区及侧颈区治疗性颈清扫和术后放射性碘消融的N1b期甲状腺乳头状癌患者。
主要发现
- 中位随访83个月(范围32-135个月),81例(18.1%)患者出现复发。
- 单因素分析显示男性、肿瘤大小、宏观甲状腺外侵犯、神经侵犯、淋巴结外侵犯、淋巴结受累、淋巴结比率、MACIS评分及术后血清甲状腺球蛋白与无复发生存显著相关(P<0.05)。
- 多因素分析显示侧颈区淋巴结比率>0.25(调整HR=2.099,95%CI 1.278-3.448,P=0.003)、术后刺激甲状腺球蛋白>5.0 ng/mL(HR=3.172,95%CI 1.661-6.056,P<0.001)和非刺激甲状腺球蛋白>0.1 ng/mL(HR=3.200,95%CI 1.569-6.526,P=0.001)是任何部位无复发生存的独立预测因素。
- 临床和肿瘤因素并非无复发生存结局的独立预测因素(P>0.1)。
临床怎么用
- 对N1b期甲状腺乳头状癌术后患者,应关注侧颈区淋巴结比率及术后刺激/非刺激甲状腺球蛋白水平以评估复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine risk factors for posttreatment recurrence in papillary thyroid carcinoma (PTC) patients with initial presentation of lateral neck metastasis (N1b). SUMMARY OF BACKGROUND DATA: N1b PTC recurs after definitive treatment. METHODS: Study subjects were 437 consecutive PTC patients who underwent total thyroidectomy and therapeutic neck dissection of central and lateral compartments and postoperative radioactive iodine ablation therapy. The patients' demographics and pathological factors, including factors related to tumors and lymph nodes (LNs), and postoperative thyroglobulin levels were reviewed. Univariate and multivariate Cox proportional hazards regression analyses were used to identify factors associated with recurrence-free survival (RFS). RESULTS: During a median follow-up of 83 months (range, 32-135 months), recurrence occurred in 81 (18.1%) patients. Univariate analyses showed that male sex, tumor size, macroscopic extrathyroidal extension, perineural invasion, extranodal extension, LN involvement, LN ratio, MACIS score, and postoperative serum levels of thyroglobulin were significantly associated with RFS (P < 0.05). Multivariate analyses revealed that LN ratio (> 0.25) in the lateral compartment (adjusted hazard ratio = 2.099, 95% confidence interval = 1.278-3.448; P = 0.003), and postoperative serum levels of stimulated (>5.0 ng/mL; 3.172, 1.661-6.056, P < 0.001) and unstimulated (>0.1 ng/mL; 3.200, 1.569-6.526, P = 0.001) thyroglobulin were independent predictors of any-site RFS. Clinical and tumor factors were not independent predictors of RFS outcomes (P > 0.1). CONCLUSIONS: Posttreatment recurrence is predicted by the LN ratio in the lateral compartment and postoperative serum levels of thyroglobulin in patients with metastatic PTC in the lateral neck.
引用
- Lee SH, Roh JL, Gong G, et al. Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma. Ann Surg. 2019. PMID: 29462007. doi:10.1097/SLA.0000000000002710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。